Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Oskui PM, French WJ, Herring MJ, Mayeda GS, Burstein S, Kloner RA.

J Am Heart Assoc. 2013 Nov 15;2(6):e000272. doi: 10.1161/JAHA.113.000272. Review. No abstract available.

2.

Testosterone and the cardiovascular system: a comprehensive review of the basic science literature.

Herring MJ, Oskui PM, Hale SL, Kloner RA.

J Am Heart Assoc. 2013 Jul 10;2(4):e000271. doi: 10.1161/JAHA.113.000271. Review. No abstract available.

3.

Testosterone, aging and survival: biomarker or deficiency.

Shores MM, Matsumoto AM.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):209-16. doi: 10.1097/MED.0000000000000057. Review.

4.

Reactive oxygen species: players in the cardiovascular effects of testosterone.

Tostes RC, Carneiro FS, Carvalho MH, Reckelhoff JF.

Am J Physiol Regul Integr Comp Physiol. 2016 Jan 1;310(1):R1-14. doi: 10.1152/ajpregu.00392.2014. Epub 2015 Nov 4. Review.

5.

Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.

García-Cruz E, Leibar-Tamayo A, Romero J, Piqueras M, Luque P, Cardeñosa O, Alcaraz A.

J Sex Med. 2013 Oct;10(10):2529-38. doi: 10.1111/jsm.12265. Epub 2013 Jul 30.

PMID:
23898860
6.

Testosterone and cardiovascular risk in men.

Kelly DM, Jones TH.

Front Horm Res. 2014;43:1-20. doi: 10.1159/000360553. Epub 2014 Jun 10. Review.

PMID:
24943294
7.

The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.

Krysiak R, Gilowski W, Okopień B.

Pharmacol Rep. 2016 Feb;68(1):75-9. doi: 10.1016/j.pharep.2015.06.003. Epub 2015 Jun 19.

PMID:
26721356
8.

The effect of testosterone on cardiovascular disease: a critical review of the literature.

Su JJ, Park SK, Hsieh TM.

Am J Mens Health. 2014 Nov;8(6):470-91. doi: 10.1177/1557988314522642. Epub 2014 Feb 20. Review.

PMID:
24563500
9.

Cardiovascular disease risk in young people with type 1 diabetes.

Snell-Bergeon JK, Nadeau K.

J Cardiovasc Transl Res. 2012 Aug;5(4):446-62. doi: 10.1007/s12265-012-9363-x. Epub 2012 Apr 12. Review. Erratum in: J Cardiovasc Transl Res. 2012 Aug;5(4):554.

PMID:
22528676
10.

Welcoming low testosterone as a cardiovascular risk factor.

Maggio M, Basaria S.

Int J Impot Res. 2009 Jul-Aug;21(4):261-4. doi: 10.1038/ijir.2009.25. Epub 2009 Jun 18. Review.

11.

Testosterone deficiency: a risk factor for cardiovascular disease?

Jones TH.

Trends Endocrinol Metab. 2010 Aug;21(8):496-503. doi: 10.1016/j.tem.2010.03.002. Epub 2010 Apr 8. Review.

PMID:
20381374
12.

Testosterone and diabetes. What's the connection?

Clark W.

Diabetes Self Manag. 2004 Sep-Oct;21(5):100-3. No abstract available.

PMID:
15586917
13.

Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.

Altara R, Manca M, Brandão RD, Zeidan A, Booz GW, Zouein FA.

Clin Sci (Lond). 2016 Apr 1;130(7):463-78. doi: 10.1042/CS20150666. Review.

PMID:
26888559
14.

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23.

15.

Age-related changes in testosterone and the role of replacement therapy in older men.

Allan CA, McLachlan RI.

Clin Endocrinol (Oxf). 2004 Jun;60(6):653-70. Review. No abstract available.

PMID:
15163327
16.

Testosterone and mortality.

Muraleedharan V, Jones TH.

Clin Endocrinol (Oxf). 2014 Oct;81(4):477-87. doi: 10.1111/cen.12503. Epub 2014 Jul 7. Review.

PMID:
25041142
17.

[Testosterone deficit: what's new?].

Zitzmann M.

Dtsch Med Wochenschr. 2015 Feb;140(3):160-2. doi: 10.1055/s-0041-100250. Epub 2015 Feb 6. Review. German. No abstract available.

PMID:
25658399
18.

Controversy over Cardiovascular Risks of Testosterone Therapy.

Carter D.

Am J Nurs. 2015 May;115(5):17. doi: 10.1097/01.NAJ.0000465018.88189.53. No abstract available.

PMID:
25906216
19.

Leptin and the cardiovascular system - a target for therapeutic interventions.

Beltowski J.

Curr Pharm Des. 2014;20(4):601-2. No abstract available.

PMID:
23688018
20.

Testosterone replacement therapy and cardiovascular risk factors modification.

Chahla EJ, Hayek ME, Morley JE.

Aging Male. 2011 Jun;14(2):83-90. doi: 10.3109/13685538.2010.541538.

PMID:
21539436

Supplemental Content

Support Center